Solubility Modeling for Key Organic Compounds Used in Adavosertib (Anticancer API) Manufacturing
Saved in:
| Main Authors: | Matthew Blair, Mazaher M. Chalchooghi, Robert J. Cox, Dimitrios I. Gerogiorgis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-06-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.5c01526 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma
by: Stephanie Cham, et al.
Published: (2025-08-01) -
Laser Microinterferometry for API Solubility and Phase Equilibria: Darunavir as a Case Example
by: Veronika Makarova, et al.
Published: (2025-07-01) -
Phenolic compounds, organic acids, methylxanthines and soluble sugars profiles in cocoa placenta
by: K. A. Goudé, et al.
Published: (2025-04-01) -
Impact of Molybdenum Compounds as Anticancer Agents
by: Ayodele T. Odularu, et al.
Published: (2019-01-01) -
Anticancer Mechanisms of Ginsenoside Compound K: A Review
by: Yu-Po Lee, et al.
Published: (2025-05-01)